Andrew graduated from Manchester University in 1986 and undertook a SERC funded PhD in Genetics also at Manchester University which was awarded in 1991. He began working in Clinical Molecular Genetics at St Mary’s Hospital, Manchester in 1989.
Andrew has a long standing interest in the genetics and molecular diagnosis of Neurofibromatosis type 2 and new assay development. He has recently been active in developing services for Molecular Pathology of Solid Tumours, a rapidly emerging field of diagnostics for stratified medicine.
Andrew was appointed as a Consultant Clinical Scientist in 2011 and since the merger of the former Cytogenetic and Molecular Genetic Laboratories to form the Genomic Diagnostics Laboratory has headed the Cancer Services Section. Andrew is currently an Examiner for the Royal College of Pathologists and has served on the CMGS Executive Committee, the BSHG Council and the CMGS Trainee Accreditation Board.